Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BVS | US
-0.18
-2.00%
Healthcare
Medical Devices
30/06/2024
07/04/2026
8.84
8.98
9.04
8.70
Bioventus Inc. a medical device company focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments which comprise non-surgical joint pain injection therapies as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices used for precise bone sculpting removing tumors and tissue debridement. The company's restorative therapies include a bone healing system; skin allografts; and products that are used to support healing of wounds as well as devices designed to help patients regain leg or hand function due to stroke multiple sclerosis or other central nervous system disorders. It serves physicians spanning the orthopedic continuum including sports medicine total joint reconstruction hand and upper extremities foot and ankle podiatric surgery trauma spine and neurosurgery in the physician's office or clinic ambulatory surgical centers or in the hospital setting. The company was founded in 2011 and is headquartered in Durham North Carolina.
View LessStrong Revenue Growth (> 10%)
Weakness based on declining price with high volume
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
27.8%1 month
35.0%3 months
39.1%6 months
46.6%-
17.67
5.42
2.62
0.50
38.09
2.18
2.14
49.00M
576.25M
576.25M
-
10.12
-
10.30
-25.82
2.85
3.40
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.75
Range1M
1.28
Range3M
2.06
Rel. volume
1.35
Price X volume
5.65M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Cytek Biosciences Inc. Common Stock | CTKB | Medical Devices | 4.6 | 604.93M | 1.77% | n/a | 8.53% |
| Tactile Systems Technology Inc | TCMD | Medical Devices | 24.05 | 576.40M | -2.12% | 10.39 | 23.72% |
| MiMedx Group Inc | MDXG | Medical Devices | 3.86 | 566.68M | -0.52% | 10.21 | 11.46% |
| SI-BONE Inc | SIBN | Medical Devices | 13.17 | 549.11M | -0.30% | n/a | 24.28% |
| Embecta Corp | EMBC | Medical Instruments & Supplies | 8.83 | 509.51M | -1.12% | 11.37 | -216.41% |
| Orthofix International N.V | OFIX | Medical Devices | 11.71 | 447.03M | -0.51% | n/a | 28.63% |
| Neuropace Inc. Common Stock | NPCE | Medical Devices | 14.51 | 423.65M | -0.62% | n/a | 745.17% |
| AngioDynamics Inc | ANGO | Medical Instruments & Supplies | 9.7 | 394.15M | -1.42% | n/a | 2.44% |
| OrthoPediatrics Corp | KIDS | Medical Devices | 15.76 | 381.62M | -1.13% | n/a | 3.67% |
| Common Stock | VMD | Medical Devices | 9.61 | 373.12M | -1.54% | 39.96 | 10.44% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Latham Group Inc. | SWIM | Building Products & Equipment | 5.17 | 597.53M | -2.08% | 65.18 | 77.00% |
| Ennis Inc | EBF | Building Products & Equipment | 21.72 | 564.80M | -0.23% | 13.28 | 2.28% |
| The Real Brokerage Inc. Common Shares | REAX | Real Estate Services | 2.45 | 484.50M | -3.16% | n/a | 0.00% |
| FRP Holdings Inc | FRPH | Real Estate Services | 22.13 | 421.14M | -0.23% | 75.50 | 42.65% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 2.84 | 272.07M | -1.73% | n/a | 174.23% |
| The RMR Group Inc | RMR | Real Estate Services | 15.81 | 264.42M | -0.50% | 16.64 | 14.14% |
| Comstock Holding Companies Inc | CHCI | Real Estate Services | 18.85 | 185.90M | -2.43% | 14.10 | 17.12% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 16.33 | 182.21M | -1.27% | 15.61 | -621.78% |
| RE/MAX Holdings Inc | RMAX | Real Estate Services | 5.74 | 180.33M | -1.20% | n/a | 114.28% |
| Douglas Elliman Inc. | DOUG | Real Estate Services | 1.6 | 146.93M | -4.19% | n/a | 62.82% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 38.09 | 46.09 | Par |
| Ent. to Revenue | 2.18 | 14.34 | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 5.42 | 6.21 | Par |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 39.13 | 64.12 | Lower Risk |
| Debt to Equity | 2.62 | -145.53 | Expensive |
| Debt to Assets | 0.50 | 0.35 | Expensive |
| Market Cap | 576.25M | 9.70B | Emerging |